Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breast Screening Atypia and Subsequent Development of Cancer: an Observational Analysis of the Sloane Database in England (Sloane Atypia Cohort Study)

NCT05402436 is registered in ClinicalTrials.gov with University of Warwick as lead sponsor.

NCT NCT05402436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05402436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breast Screening Atypia and Subsequent Development of Cancer: an Observational Analysis of the Sloane Database in England (Sloane Atypia Cohort Study)
Lead sponsor
University of Warwick
Phase
Observational
Overall status
Completed
Start date
December 1, 2021
Completion date
December 30, 2023
Enrollment
3,238 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer